KPIs & Operating Metrics(New)

National Health Investors (NHI) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for National Health Investors (NHI) over the last 17 years, with Q3 2025 value amounting to $0.69.

  • National Health Investors' EPS (Weighted Average and Diluted) rose 615.38% to $0.69 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.18, marking a year-over-year increase of 927.84%. This contributed to the annual value of $3.13 for FY2024, which is 2.99% up from last year.
  • Latest data reveals that National Health Investors reported EPS (Weighted Average and Diluted) of $0.69 as of Q3 2025, which was up 615.38% from $0.79 recorded in Q2 2025.
  • In the past 5 years, National Health Investors' EPS (Weighted Average and Diluted) registered a high of $0.98 during Q4 2024, and its lowest value of $0.05 during Q4 2022.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $0.74 (2023), whereas its average is $0.65.
  • In the last 5 years, National Health Investors' EPS (Weighted Average and Diluted) crashed by 8433.73% in 2021 and then surged by 137625.69% in 2023.
  • Over the past 5 years, National Health Investors' EPS (Weighted Average and Diluted) (Quarter) stood at $0.13 in 2021, then tumbled by 61.54% to $0.05 in 2022, then skyrocketed by 1376.26% to $0.74 in 2023, then surged by 32.75% to $0.98 in 2024, then fell by 29.58% to $0.69 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.69 in Q3 2025, compared to $0.79 in Q2 2025 and $0.74 in Q1 2025.